stockrowKoninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) Return on assets
Koninklijke Philips N.V.'s return on assets over the twelve months to 30 September 2026 was 3.49%, up 0.2 percentage points from fiscal 2025 (3.27%). Over the past ten years it has ranged from −4.91% (fiscal 2022) to 11.5% (fiscal 2021); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 3.27% | 5.67 |
| FY2024 | −2.40% | (0.83) |
| FY2023 | −1.57% | 3.34 |
| FY2022 | −4.91% | (16.41) |
| FY2021 | 11.5% | 7.12 |
| FY2020 | 4.38% | 0.09 |
| FY2019 | 4.29% | (0.05) |
| FY2018 | 4.34% | (1.48) |
| FY2017 | 5.82% | 1.25 |
| FY2016 | 4.57% | 2.58 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.4% |
| BSX Boston Scientific Corporation compare | 7.94% |
| STE STERIS plc compare | 7.83% |
| EW Edwards Lifesciences Corporation compare | 7.45% |
| GEHC GE HealthCare Technologies Inc. compare | 5.78% |
| PHG Koninklijke Philips N.V. | 3.49% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.26% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| GKOS Glaukos Corporation compare | −17.2% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement